{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T01:43:16Z","timestamp":1785548596750,"version":"3.56.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T00:00:00Z","timestamp":1764892800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T00:00:00Z","timestamp":1764892800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ophthalmol Ther"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1007\/s40123-025-01289-7","type":"journal-article","created":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T05:27:55Z","timestamp":1764912475000},"page":"415-426","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Tolerability of 0.5% Liposomal Ozonated Oil Versus 0.6% Povidone-Iodine in Antiseptic Prophylaxis for Intravitreal Injections"],"prefix":"10.1007","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4725-1590","authenticated-orcid":false,"given":"Marco R.","family":"Pastore","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Verdimonti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamal","family":"El Majdoubi El Idrissi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianna","family":"Presotto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Borelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Miere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniele","family":"Tognetto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric H.","family":"Souied","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,5]]},"reference":[{"key":"1289_CR1","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1159\/000486145","volume":"239","author":"A Grzybowski","year":"2018","unstructured":"Grzybowski A, Told R, Sacu S, et al. 2018 update on intravitreal injections: Euretina expert consensus recommendations. Ophthalmologica. 2018;239:181\u201393.","journal-title":"Ophthalmologica"},{"issue":"7","key":"1289_CR2","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1016\/j.oret.2020.09.024","volume":"5","author":"MS Ramos","year":"2021","unstructured":"Ramos MS, Xu LT, Singuri S, et al. Patient-reported complications after intravitreal injection and their predictive factors. Ophthalmol Retina. 2021;5(7):625\u201332.","journal-title":"Ophthalmol Retina"},{"key":"1289_CR3","doi-asserted-by":"publisher","first-page":"2399","DOI":"10.1007\/s00417-022-05607-8","volume":"260","author":"R Singh","year":"2022","unstructured":"Singh R, Davoudi S, Ness S. Preventive factors, diagnosis, and management of injection-related endophthalmitis: a literature review. Graefes Arch Clin Exp Ophthalmol. 2022;260:2399\u2013416.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"9","key":"1289_CR4","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1038\/s41433-018-0138-8","volume":"32","author":"F Menchini","year":"2018","unstructured":"Menchini F, Toneatto G, Miele A, Donati S, Lanzetta P, Virgili G. Antibiotic prophylaxis for preventing endophthalmitis after intravitreal injection: a systematic review. Eye (Lond). 2018;32(9):1423\u201331.","journal-title":"Eye (Lond)"},{"key":"1289_CR5","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1097\/IAE.0b013e31816b3180","volume":"28","author":"JJ De Caro","year":"2008","unstructured":"De Caro JJ, Ta CN, Ho HK, et al. Bacterial contamination of ocular surface and needles in patients undergoing intravitreal injections. Retina. 2008;28:877\u201383.","journal-title":"Retina"},{"key":"1289_CR6","first-page":"325","volume":"89","author":"LJ Lu","year":"2016","unstructured":"Lu LJ, Liu J. Human microbiota and ophthalmic disease. Yale J Biol Med. 2016;89:325\u201330.","journal-title":"Yale J Biol Med"},{"issue":"1","key":"1289_CR7","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1186\/s12886-025-04093-w","volume":"25","author":"S Comcali","year":"2025","unstructured":"Comcali S, Tasci YY, Onen M, et al. Endophthalmitis following intravitreal injections at a tertiary center: real-life data on incidence, risk factors, management strategies, and visual outcomes. BMC Ophthalmol. 2025;25(1):278.","journal-title":"BMC Ophthalmol"},{"key":"1289_CR8","doi-asserted-by":"publisher","first-page":"143","DOI":"10.3928\/23258160-20140306-08","volume":"45","author":"JB Fileta","year":"2014","unstructured":"Fileta JB, Scott IU, Flynn HW Jr. Meta-analysis of infectious endophthalmitis after intravitreal injection of anti-VEGF agents. Ophthalmic Surg Lasers Imaging Retina. 2014;45:143\u20139.","journal-title":"Ophthalmic Surg Lasers Imaging Retina"},{"key":"1289_CR9","doi-asserted-by":"publisher","first-page":"643","DOI":"10.3928\/23258160-20150610-08","volume":"46","author":"NZ Gregori","year":"2015","unstructured":"Gregori NZ, Flynn HW, Schwartz SG, et al. Current infectious endophthalmitis rates after intravitreal injections of anti-VEGF agents and outcomes of treatment. Ophthalmic Surg Lasers Imaging Retina. 2015;46:643\u20138.","journal-title":"Ophthalmic Surg Lasers Imaging Retina"},{"issue":"7","key":"1289_CR10","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1001\/archopht.125.7.974","volume":"125","author":"IU Scott","year":"2007","unstructured":"Scott IU, Flynn HW Jr. The role of topical antibiotic prophylaxis for intravitreal injections. Arch Ophthalmol. 2007;125(7):974\u20136.","journal-title":"Arch Ophthalmol"},{"key":"1289_CR11","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1111\/aos.13417","volume":"96","author":"AP Hunyor","year":"2018","unstructured":"Hunyor AP, Merani R, Darbar A, et al. Topical antibiotics and intravitreal injections. Acta Ophthalmol. 2018;96:435\u201341.","journal-title":"Acta Ophthalmol"},{"issue":"7","key":"1289_CR12","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.3390\/microorganisms10071390","volume":"10","author":"F Petrillo","year":"2022","unstructured":"Petrillo F, Petrillo A, Marrapodi M, et al. Characterization and comparison of ocular surface microbiome in newborns. Microorganisms. 2022;10(7):1390.","journal-title":"Microorganisms"},{"issue":"6","key":"1289_CR13","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1097\/APO.0000000000000330","volume":"9","author":"JAP Gomes","year":"2020","unstructured":"Gomes JAP, Frizon L, Demeda VF. Ocular surface microbiome in health and disease. Asia-Pac J Ophthalmol. 2020;9(6):505\u201311.","journal-title":"Asia-Pac J Ophthalmol"},{"key":"1289_CR14","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1159\/000310878","volume":"211","author":"U Pleyer","year":"1997","unstructured":"Pleyer U, Baatz H. Antibacterial protection of the ocular surface. Ophthalmologica. 1997;211:2\u20138.","journal-title":"Ophthalmologica"},{"issue":"10","key":"1289_CR15","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0205814","volume":"13","author":"PA Asbell","year":"2018","unstructured":"Asbell PA, DeCory HH. Antibiotic resistance among bacterial conjunctival pathogens collected in the ARMOR surveillance study. PLoS ONE. 2018;13(10):e0205814.","journal-title":"PLoS ONE"},{"key":"1289_CR16","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/8567912","volume":"2018","author":"PE Lau","year":"2018","unstructured":"Lau PE, Jenkins KS, Layton CJ. Current evidence for the prevention of endophthalmitis in anti-VEGF intravitreal injections. J Ophthalmol. 2018;2018:8567912.","journal-title":"J Ophthalmol"},{"issue":"1","key":"1289_CR17","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1007\/s00417-021-05361-3","volume":"260","author":"D Tognetto","year":"2022","unstructured":"Tognetto D, Pastore MR, Guerin GM, et al. Bactericidal activity of three different antiseptic ophthalmic preparations as surgical prophylaxis. Graefes Arch Clin Exp Ophthalmol. 2022;260(1):289\u201393.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"1289_CR18","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-02831-w","volume":"11","author":"D Tognetto","year":"2021","unstructured":"Tognetto D, Pastore MR, Belfanti L, et al. In vivo antimicrobial activity of 0.6% povidone-iodine eye drops in patients undergoing intravitreal injections: a prospective study. Sci Rep. 2021;11:23271.","journal-title":"Sci Rep"},{"issue":"8","key":"1289_CR19","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1016\/j.oret.2020.11.008","volume":"5","author":"FS Ali","year":"2021","unstructured":"Ali FS, Jenkins TL, Boparai RS, et al. Aqueous chlorhexidine compared with povidone-iodine as ocular antisepsis before intravitreal injection: a randomized clinical trial. Ophthalmol Retina. 2021;5(8):788\u201396.","journal-title":"Ophthalmol Retina"},{"issue":"12","key":"1289_CR20","doi-asserted-by":"publisher","first-page":"1548","DOI":"10.1097\/j.jcrs.0000000000000672","volume":"47","author":"L Spadea","year":"2021","unstructured":"Spadea L, Zanotto E, Cavallo R, et al. Effectiveness of liposomal ozonized oil in reducing ocular microbial flora in patients undergoing cataract surgery. J Cataract Refract Surg. 2021;47(12):1548\u201355.","journal-title":"J Cataract Refract Surg"},{"key":"1289_CR21","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1097\/ICU.0000000000000437","volume":"29","author":"A Grzybowski","year":"2018","unstructured":"Grzybowski A, Kanclerz P, Myers WG. The use of povidone-iodine in ophthalmology. Curr Opin Ophthalmol. 2018;29:19\u201332.","journal-title":"Curr Opin Ophthalmol"},{"key":"1289_CR22","doi-asserted-by":"publisher","first-page":"398","DOI":"10.5301\/ejo.5000738","volume":"26","author":"A Grosso","year":"2016","unstructured":"Grosso A, Pertile G, Marchini G, et al. Adherence to ESCRS recommendations among Italian cataract surgeons: a survey. Eur J Ophthalmol. 2016;26:398\u2013404.","journal-title":"Eur J Ophthalmol"},{"issue":"2","key":"1289_CR23","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.survophthal.2023.11.002","volume":"69","author":"M Soleimani","year":"2024","unstructured":"Soleimani M, Haydar AA, Cheraqpour K, et al. In praise of povidone-iodine application in ophthalmology. Surv Ophthalmol. 2024;69(2):211\u201323.","journal-title":"Surv Ophthalmol"},{"key":"1289_CR24","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.3390\/jcm8071031","volume":"8","author":"M Reibaldi","year":"2019","unstructured":"Reibaldi M, Avitabile T, Bandello F, et al. Effectiveness of 0.6% povidone-iodine eye drops in reducing conjunctival bacterial load and needle contamination in anti-VEGF intravitreal injection. J Clin Med. 2019;8:1031.","journal-title":"J Clin Med."},{"key":"1289_CR25","doi-asserted-by":"publisher","first-page":"e178","DOI":"10.1111\/aos.14243","volume":"98","author":"A Pinna","year":"2020","unstructured":"Pinna A, Donadu MG, Usai D, et al. In vitro antimicrobial activity of an ophthalmic solution containing povidone-iodine 0.6% (IODIM). Acta Ophthalmol. 2020;98:e178\u201380.","journal-title":"Acta Ophthalmol."},{"issue":"2","key":"1289_CR26","doi-asserted-by":"publisher","first-page":"334","DOI":"10.3390\/molecules25020334","volume":"25","author":"E Ugazio","year":"2020","unstructured":"Ugazio E, Tullio V, Binello A, et al. Ozonated oils as antimicrobial systems in topical applications. Molecules. 2020;25(2):334.","journal-title":"Molecules"},{"issue":"3","key":"1289_CR27","doi-asserted-by":"publisher","first-page":"679","DOI":"10.3390\/molecules29030679","volume":"29","author":"S Puxeddu","year":"2024","unstructured":"Puxeddu S, Scano A, Scorciapino MA, et al. Physico-chemical investigation and antimicrobial efficacy of ozonated oils. Molecules. 2024;29(3):679.","journal-title":"Molecules"},{"issue":"5","key":"1289_CR28","doi-asserted-by":"publisher","first-page":"1422","DOI":"10.1111\/1751-7915.13949","volume":"15","author":"L Zerillo","year":"2022","unstructured":"Zerillo L, Polvere I, Varricchio R, et al. Antibiofilm and repair activity of ozonated oil in liposome. Microb Biotechnol. 2022;15(5):1422\u201333.","journal-title":"Microb Biotechnol"},{"key":"1289_CR29","doi-asserted-by":"publisher","first-page":"968","DOI":"10.3390\/antiox10060968","volume":"10","author":"R Paduch","year":"2021","unstructured":"Paduch R, Urbanik-Sypniewska T, Kutkowska J, et al. Ozone-based eye drops activity on ocular epithelial cells and potential pathogens. Antioxidants. 2021;10:968.","journal-title":"Antioxidants"},{"issue":"7","key":"1289_CR30","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/S1526-5900(03)00716-8","volume":"4","author":"MP Jensen","year":"2003","unstructured":"Jensen MP, Chen C, Brugger AM. Interpretation of visual analog scale ratings and change scores. J Pain. 2003;4(7):407\u201314.","journal-title":"J Pain"},{"issue":"3","key":"1289_CR31","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1198\/106186006X133933","volume":"15","author":"T Hothorn","year":"2006","unstructured":"Hothorn T, Hornik K, Zeileis A. Unbiased recursive partitioning: a conditional inference framework. J Comput Graph Stat. 2006;15(3):651\u201374.","journal-title":"J Comput Graph Stat"},{"key":"1289_CR32","unstructured":"JASP Team. JASP version 0.19.2. 2024. https:\/\/jasp-stats.org\/."},{"key":"1289_CR33","volume-title":"R: a language and environment for statistical computing","author":"R Core Team","year":"2024","unstructured":"R Core Team. R: a language and environment for statistical computing. Vienna: R Foundation; 2024."},{"key":"1289_CR34","doi-asserted-by":"publisher","first-page":"1953","DOI":"10.2147\/OPTH.S360929","volume":"16","author":"JJ P\u00e9rez-Santonja","year":"2022","unstructured":"P\u00e9rez-Santonja JJ, G\u00fcell JL, Gris O, et al. Liposomal ozonated oil in ocular infections: review of preclinical and clinical studies. Clin Ophthalmol. 2022;16:1953\u201362.","journal-title":"Clin Ophthalmol"},{"issue":"7","key":"1289_CR35","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1097\/j.jcrs.0000000000001436","volume":"50","author":"D Teren","year":"2024","unstructured":"Teren D, Neuman G, Abulafia A, et al. In vivo antimicrobial activity and toxicity of repeated 1% vs single 5% povidone-iodine applications. J Cataract Refract Surg. 2024;50(7):682\u20137.","journal-title":"J Cataract Refract Surg"},{"issue":"3","key":"1289_CR36","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1177\/11206721231207116","volume":"34","author":"JM Ben\u00edtez-Del-Castillo","year":"2024","unstructured":"Ben\u00edtez-Del-Castillo JM. Liposomal ozonated oil effectiveness in blepharitis. Eur J Ophthalmol. 2024;34(3):678\u201382.","journal-title":"Eur J Ophthalmol"},{"issue":"3","key":"1289_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.clae.2025.102368","volume":"48","author":"MC S\u00e1nchez-Gonz\u00e1lez","year":"2025","unstructured":"S\u00e1nchez-Gonz\u00e1lez MC, Gallardo-Real I, Guti\u00e9rrez-S\u00e1nchez E, et al. Ocular microbiota in contact lens wearers: efficacy of liposomal ozonated oil. Cont Lens Anterior Eye. 2025;48(3):102368.","journal-title":"Cont Lens Anterior Eye"},{"key":"1289_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2024.124046","volume":"655","author":"VK Panthi","year":"2024","unstructured":"Panthi VK, Fairfull-Smith KE, Islam N. Liposomal drug delivery strategies to eradicate bacterial biofilms. Int J Pharm. 2024;655:124046.","journal-title":"Int J Pharm"},{"issue":"9","key":"1289_CR39","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1167\/tvst.10.9.7","volume":"10","author":"S Rizzo","year":"2021","unstructured":"Rizzo S, Savastano MC, Bortolotti D, et al. COVID-19 ocular prophylaxis: potential role of ozonated oils. Transl Vis Sci Technol. 2021;10(9):7.","journal-title":"Transl Vis Sci Technol"},{"issue":"8","key":"1289_CR40","doi-asserted-by":"publisher","DOI":"10.1167\/tvst.9.8.4","volume":"9","author":"G Celenza","year":"2020","unstructured":"Celenza G, Iorio R, Cracchiolo S, et al. Antimycotic activity of ozonized oil in liposome eye drops against Candida spp. Transl Vis Sci Technol. 2020;9(8):4.","journal-title":"Transl Vis Sci Technol"},{"key":"1289_CR41","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.ajo.2025.03.031","volume":"276","author":"A Mihalache","year":"2025","unstructured":"Mihalache A, Tao BK, Huang RS, et al. Chlorhexidine versus povidone-iodine for intravitreal injection antisepsis: systematic review and meta-analysis. Am J Ophthalmol. 2025;276:64\u201377.","journal-title":"Am J Ophthalmol"}],"container-title":["Ophthalmology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40123-025-01289-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40123-025-01289-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40123-025-01289-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T08:32:42Z","timestamp":1770453162000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40123-025-01289-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,5]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["1289"],"URL":"https:\/\/doi.org\/10.1007\/s40123-025-01289-7","relation":{},"ISSN":["2193-8245","2193-6528"],"issn-type":[{"value":"2193-8245","type":"print"},{"value":"2193-6528","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,5]]},"assertion":[{"value":"26 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Marco R. Pastore, Elena Verdimonti, Kamal El Majdoubi El Idrissi, Marianna Presotto, Massimo Borelli, Alexandra Miere, Daniele Tognetto, and Eric H. Souied confirm that they have no competing interests to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This study adhered to the tenets of the Declaration of Helsinki and the guidelines of Good Clinical Practice. The institutional ethics committee approved the research protocol (Comit\u00e9 de protection des personnes du Centre Hospitalier Intercommunal de Cr\u00e9teil\u201461.03.24, and Comitato etico di ateneo Universit\u00e0 degli studi di Trieste\u201474\/24), and written informed consent was obtained from all participants.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}